PLACENTAL ALPHA-1-MICROGLOBULIN (PAMG-1) - ANVISA Registration 10322250136
Access comprehensive regulatory information for PLACENTAL ALPHA-1-MICROGLOBULIN (PAMG-1) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10322250136 and manufactured by QIAGEN. The registration is held by QIAGEN BIOTECNOLOGIA BRASIL LTDA. with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 1 companies making the same product including QIAGEN, and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10322250136
25351107594202596
01334250000120
Company Information
Dates and Status
Aug 18, 2025
VIGENTE
09/18/2025 19:00:01
ALFA-MICROGLOBULINA-1 PLACENTÁRIA (PAMG-1)
Partosure
QIAGEN
10322250094
Nov 25, 2019
ALFA-MICROGLOBULINA-1 PLACENTÁRIA (PAMG-1)
AmniSure – Teste para Detecção de Ruptura de Membrana Fetal
QIAGEN
10322250050
Sep 02, 2013

